Endonovo Therapeutics Inc (ENDV)

[BMOC91324]

Please provide your thoughts re: bioelectricity and stem cell 3D printing technology...Both ENDV and Organovo Holdings (ONVO) use stem cells to engineer organs in vitro for donors... they both are also targetting their liver organ sales as a more cost effective alternative to pre clinical toxicity test in animals...they both generate no revenues but ONVO is traded on Nasdaq with a 300 mil market cap... is it possible that ENDV could exceed this market cap given the potentially additional regenerative capabilities of ENDV due to the non implantable device.

Also, I was hoping one of you could kindly provide a link re: the minimum market cap required for the uplisting; the Nasdaq listing website indicates a minimum $8 million market value for the float which doesn't seem too unattainable.

Thanks and may all patients and long investors benefit from this revolution of bioelectric and stem cell technology